• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy.

作者信息

Wendling D, Auge B, Bettinger D, Lohse A, Le Huede G, Bresson-Hadni S, Toussirot E, Miguet J-P, Herbein G, Di Martino V

出版信息

Ann Rheum Dis. 2005 May;64(5):788-9. doi: 10.1136/ard.2004.031187.

DOI:10.1136/ard.2004.031187
PMID:15834064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1755487/
Abstract
摘要

相似文献

1
Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy.在使用英夫利昔单抗治疗重度脊柱关节病期间，潜伏性前核心突变型乙型肝炎病毒相关慢性肝炎的再激活。
Ann Rheum Dis. 2005 May;64(5):788-9. doi: 10.1136/ard.2004.031187.
2
Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy.脊柱关节病与慢性乙型肝炎。抗TNF治疗的效果。
Joint Bone Spine. 2009 May;76(3):308-11. doi: 10.1016/j.jbspin.2008.11.005. Epub 2009 Apr 5.
3
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.抗 TNF 治疗在患有风湿性疾病和慢性或已解决的乙型肝炎病毒感染患者中的长期安全性。
Ann Rheum Dis. 2010 Jul;69(7):1352-5. doi: 10.1136/ard.2009.127233. Epub 2010 May 14.
4
Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab.使用英夫利昔单抗治疗的克罗恩病患者出现乙肝再激活。
J Gastroenterol. 2008;43(5):397-401. doi: 10.1007/s00535-008-2165-x. Epub 2008 Jul 1.
5
Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies.潜在隐匿性乙型肝炎病毒携带者慢性炎症性关节炎应用肿瘤坏死因子拮抗剂治疗后病毒无再激活。
Eur J Intern Med. 2014 Jun;25(5):482-4. doi: 10.1016/j.ejim.2013.11.014. Epub 2014 Feb 2.
6
Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infection.在一名乙肝表面抗原阴性且临床乙肝病毒感染已缓解的患者中，阿达木单抗诱发致死性乙肝病毒再激活。
Liver Int. 2010 Sep;30(8):1241-2. doi: 10.1111/j.1478-3231.2010.02238.x. Epub 2010 Mar 22.
7
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.英夫利昔单抗治疗克罗恩病患者后发生慢性乙型肝炎再激活：需要进行一级预防。
Gut. 2004 Sep;53(9):1363-5. doi: 10.1136/gut.2004.040675.
8
Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.HBV 核心抗体阳性的类风湿关节炎患者接受抗 TNF-α 治疗时病毒载量的动力学变化及乙型肝炎病毒再激活的风险。
Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.
9
Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.HBsAg 阳性的风湿性疾病患者在接受抗肿瘤坏死因子治疗或 DMARDs 治疗时乙型肝炎病毒再激活。
Int J Rheum Dis. 2013 Oct;16(5):527-31. doi: 10.1111/1756-185X.12154.
10
Infliximab and reactivation of cerebral toxoplasmosis.英夫利昔单抗与脑型弓形虫病的再激活
N Engl J Med. 2005 Oct 6;353(14):1530-1; discussion 1530-1. doi: 10.1056/NEJMc051556.

引用本文的文献

1
Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature.急性心力衰竭作为炎症性肠病中肿瘤坏死因子抑制剂治疗的不良事件：文献综述
World J Cardiol. 2023 May 26;15(5):217-228. doi: 10.4330/wjc.v15.i5.217.
2
Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: A multicenter countrywide study.类风湿关节炎和强直性脊柱炎中乙型和丙型肝炎感染的患病率：一项全国多中心研究。
Eur J Rheumatol. 2014 Jun;1(2):51-54. doi: 10.5152/eurjrheumatol.2014.018. Epub 2014 Jun 1.
3
Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.慢性炎症性疾病的乙型肝炎与免疫抑制治疗：何时以及如何应用预防措施，特别关注皮质类固醇治疗。
World J Hepatol. 2015 Mar 27;7(3):539-47. doi: 10.4254/wjh.v7.i3.539.
4
Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model.在大鼠模型中，Wnt/β-连环蛋白信号通路的恢复可减轻酒精性肝病的进展。
J Hepatol. 2015 Jul;63(1):191-8. doi: 10.1016/j.jhep.2015.02.030. Epub 2015 Feb 24.
5
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review.免疫抑制治疗后风湿性疾病患者的肝炎再激活——系列病例长期随访报告及文献综述
Clin Rheumatol. 2014 Apr;33(4):577-86. doi: 10.1007/s10067-013-2450-9. Epub 2013 Dec 11.
6
Deterioration of the liver biochemistry due to reactivation of chronic hepatitis B during etanercept treatment for rheumatoid arthritis.类风湿关节炎患者在接受依那西普治疗期间，慢性乙型肝炎再激活导致肝脏生化指标恶化。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.09.2008.0873. Epub 2009 Mar 17.
7
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.接受癌症化疗患者的乙型肝炎病毒再激活：自然史、发病机制及管理
Hepatol Int. 2013 Jun;7(2):316-26. doi: 10.1007/s12072-011-9279-6. Epub 2011 Jun 14.
8
Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy.细胞毒性化疗或免疫抑制治疗后乙型肝炎病毒再激活。
World J Gastroenterol. 2011 Mar 28;17(12):1531-7. doi: 10.3748/wjg.v17.i12.1531.
9
[Infectious complications of biologic therapy in patients with rheumatoid arthritis].[类风湿关节炎患者生物治疗的感染并发症]
Z Rheumatol. 2010 Dec;69(10):879-88. doi: 10.1007/s00393-010-0677-2.
10
A practical approach to monitoring patients on biological agents for the treatment of psoriasis.一种监测接受生物制剂治疗银屑病患者的实用方法。
J Clin Aesthet Dermatol. 2010 Aug;3(8):20-6.